Apparent lack of pharmacological effect of steviol glycosides used as sweeteners in humans. A pilot study of repeated exposures in some normotensive and hypotensive individuals and in Type 1 and Type 2 diabetics

Regulatory Toxicology and Pharmacology

Volumn 51, Issue 1, 2008, Pages 37-41

  Barriocanal, Luis A ^a   Palacios, Mafalda ^a   Benitez, Gilda ^a   Benitez, Sussam ^a   Jimenez, Jorge T ^a   Jimenez, Nora ^b   Rojas, Vicenta ^b  

^a Faculty of Medicine   (Paraguay)

^b Laboratory Jiménez Rojas   (Paraguay)

Author keywords

Hypotension; Steviol glycosides; Type 1 diabetes mellitus; Type 2 diabetes mellitus

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT; PLACEBO; STEVIOSIDE;

ADULT; AGED; ARTICLE; ASTHENIA; BLOATING; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; HYPOTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DITERPENES, KAURANE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; GLUCOSIDES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOTENSION; INSULIN; MALE; MIDDLE AGED; PILOT PROJECTS; SWEETENING AGENTS;

STEVIA REBAUDIANA;

EID: 43749120034     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2008.02.006     Document Type: Article

References (32)

1. Bertoni M.S. El Ca'a he'e (Eupatorium rebaudianum, especies novas). Rev. Agr. Asuncion (1899) 35-37
2. Bertoni M.S. Le Ka'a he'e Sa nature et ses proprietes. An. Cient. Paraguay Ser. I 5 (1905) 1
3. Bertoni M.S. La Stevia rebaudiana Bertoni La estevia y la rebaudiana. Nuevas substancias edulcorantes. An. Cient. Paraguay Ser. II 2 (1918) 129-134
4. Briedel M., and Lavieille R. Le principe a saveur sucre du Ka'a he'e (Stevia rebaudiana Bertoni). Bull. Soc. Chim. Biol. Paris 13 (1931) 636-655
5. Chan P., Tomlinson B., Chen Y.J., et al. A double-blind placebo-controlled study of the effectiveness and tolerability of oral stevioside in human hypertension. Br. J. Clin. Pharmacol. 50 (2000) 215-220
6. Crammer B., and Ikan R. Properties and synthesis of sweetening agents. Chem. Soc. Rev. 6 (1977) 431-465
7. Curi R., Alvarez M., Bazotte R.B., Botion L.M., Godoy J.L., and Bracht A. Effect of Stevia rebaudiana on glucose tolerance in normal adult humans. Braz. J. Med. Biol. Res. 19 (1986) 771-774
8. Dieterich K. Uber die bestandteile der Paraguay. Substoffplanze Eupatorium rebaudianum Ka'a he'e und ihre phar'aceutische verwertbarkeit. Pharm. Zentralh. 50 (1909) 435-441
9. Ferri L.A., Alves-Do-Prado W., Yamada S.S., Gazola S., Batista M.R., and Bazotte R.B. Investigation of the antihypertensive effect of oral crude stevioside in patients with mild essential hypertension. Phitother. Rev. 20 9 (2006) 732-736
10. FSANZ. 2007. Steviol glycosides as intense sweeteners; final draft assessment report. Application A540. The Steviol glycosides document is available at .
11. Geuns, J.M.C., Buyse, J.G., (Eds.), 2004. The safety of Stevia. In: Proceedings of the First Symposium, KULeuvwn, April 16, 2004. Euprint ed, Parbosstraat 3, 3001 Heverlee.
12. Geuns J.M., Buyse J., Vankeirsbilck A., and Temme E.H. Metabolism of stevioside by healthy subjects. Exp. Biol. Med. (Maywood) 232 1 (2007) 164-173
13. Gregersen S., Jeppesen P.B., Holst J.J., and Hermansen K. Antihyperglycemic effects of stevioside in type 2 diabetic subjects. Metabolism 53 (2004) 73-76
14. Haebisch B. Pharmacological trial of a concentrated crude extract of Stevia rebaudiana (bert.) bertoni in healthy volunteers. Arq. Biol. Tecnol. 35 (1992) 299-314
15. Hsieh M.H., Chan P., Sue Y.M., Liu J.C., Liang T.H., Huang T.Y., Tomlinson B., Chow M.S., Kao P.F., and Chen Y.J. Efficacy and tolerability of oral stevioside in patients with mild essential hypertension: a two-year, randomized, placebo-controlled study. Clin. Ther. 25 (2003) 2797-2808
16. JECFA, 2004. Compendium of food additive specifications. Addendum 12. Sixty-third Meeting, Geneva, Italy, 8-17 June 2004, Joint FAO/WO Expert Committee on Food Additives.
17. +-channel activity. Metabolism 49 (2000) 208-214
18. Jeppesen P.B., Gregersen S., Rolfsen S.E.D., et al. Antihyperglycemic and blood-pressure reducing effects of stevioside in the diabetic Goto-Kakizaki (GK) rat. Metabolism 52 (2003) 372-378
19. Jeppesen P.B., Barriocanal L., Meyer M.T., Palacios M., Cañete F., Benitez S., Logwin S., Schupmann Y., Benitez G., and Jimenez J.T. Efficacy and tolerability of oral stevioside in patients with type 2 diabetes: a long-term, randomized, double-blinded, placebo-controlled study. Diabetologia 49 Suppl. 1 (2006) A0843
20. Kohda H., Kasai R., Yamasaki K., Murakami K., and Tanaka O. New sweet diterpene glucosides for Stevia rebaudiana. Phytochemistry 15 (1976) 981-983
21. Liu J.C., Kao P.K., Chan P., Hsu Y.H., Hou C.C., Lien G.S., Hsieh M.H., Chen Y.J., and Cheng J.T. Mechanism of the antihypertensive effect of stevioside in anesthetized dogs. Pharmacology 67 (2003) 14-20
22. Mancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Grassi, G., Heagerty, A.M., Kjeldsen, S.E., Laurent, S., Narkiewicz, K., Ruilope, L., Rynkiewicz, A., Schmieder, R.E., Boudier, H.A., Zanchetti, A., Vahanian, A., Camm, J., De Caterina, R., Dean, V., Dickstein, K., Filippatos, G., Funck-Brentano, C., Hellemans, I., Kristensen, S.D., McGregor, K., Sechtem, U., Silber, S., Tendera, M., Widimsky, P., Zamorano, J.L., Erdine, S., Kiowski, W., Agabiti-Rosei, E., Ambrosioni, E., Lindholm, L.H., Viigimaa, M., Adamopoulos, S., Agabiti-Rosei, E., Ambrosioni, E., Bertomeu, V., Clement, D., Erdine, S., Farsang, C., Gaita, D., Lip, G., Mallion, J.M., Manolis, A.J., Nilsson, P.M., O'Brien, E., Ponikowski, P., Redon, J., Ruschitzka, F., Tamargo, J., van Zwieten, P., Waeber, B., Williams, B., 2007. Management of arterial hypertension of the European society of hypertension, European society of cardiology, Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC). J. Hypertens. 25(6) 1105-1187. (Erratum in J. Hypertens. 2007 Aug, 25 (8) 1749).
23. 1c levels than glucose instability. An analysis of data from the diabetes control and complications trial. Diabetes Care 29 (2006) 352-355
24. Melis M.S. Chronic administration of aqueous extract of Stevia rebaudiana in rats: renal effects. J. Ethnopharmacol. 47 (1995) 129-134
25. Melis M.S. A crude extract of Stevia rebaudiana increases the renal plasma flow of normal and hypertensive rats. Braz. J. Med. Biol. Res. 29 (1996) 669-675
26. Nuttal F.Q. Comparison of percent total GHb with percent HbA1c in people with and without known diabetes. Diabetes Care 21 (1998) 1475-1480
27. Suanarunsawat T., and Chaiyabutr N. The effect of stevioside on glucose metabolism in rat. Can. J. Physiol. Pharmacol. 75 (1997) 976-982
28. Teuscher A., and Richterich R. New Swiss guide lines for the diagnosis of diabetes mellitus. Schweiz. Med. Wochenschr. 101 10 (1971) 345-398
29. Usami M., Seino Y., Takai J., et al. Effect of cyclamate sodium, saccharin sodium and stevioside on arginine-induced insulin and glucagon secretion in the isolated perfused rat pancreas. Horm. Metab. Res. 12 (1980) 705-706
30. Wood Jr. H.B., Allerton R., Diehl H.W., and Fletcher Jr. H.G. Stevioside 1. The structure of the glucose moieties. J. Org. Chem. 20 (1955) 875-883
31. Wood Jr. H.B., and Fletcher Jr. H.G. Stevioside. III. The anomeric 2,3,4,6-tetra-O-acetyl-1-O-mesitoyl-d-glucopyranoses and their behavior with alkali. J. Am. Chem. Soc. 78 (1956) 207-210
32. Xili L., Chengjiany B., Eryi X., Reiming S., Yuengming W., Haodong S., and Zhiyian H. Chronic oral toxicity and carcinogenicity study of stevioside in rats. Food Chem. Toxicol. 30 (1992) 957-965